Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

151.25
BATS BZX Real-Time Price
As of 12:59pm ET
 -2.68 / -1.74%
Today’s Change
147.85
Today|||52-Week Range
270.63
-26.22%
Year-to-Date

Today’s Trading

Previous close153.93
Today’s open158.73
Day’s range151.24 - 158.73
Volume1,345,743
Average volume (3 months)1,398,534
Market cap$30.4B
Dividend yield0.46%
Data as of 12:59pm ET, 02/11/2016

Growth & Valuation

Earnings growth (last year)+381.10%
Earnings growth (this year)--
Earnings growth (next 5 years)+12.20%
Revenue growth (last year)+21.90%
P/E ratio9.9
Price/Sales6.98
Price/Book3.58

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-2.19-1.58%
VRXValeant Pharmaceutic...-1.94-2.26%
MYLMylan NV-9.43-18.66%
PRGOPerrigo Company PLC-1.96-1.43%
Data as of 1:01pm ET, 02/11/2016

Financials

Last reporting dateFebruary 11, 2016
EPS forecast (this quarter)$2.87
Annual revenue (last year)$6.0B
Annual profit (last year)$3.4B
Net profit margin54.51%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Flemming Ornskov
Chief Financial Officer &
Executive Director
Jeffrey Poulton
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers